Smoking Cessation and Nicotine De-addiction Products Market to Witness Significant Growth with High Number of Substance Users
Smoking cessation is tremendously beneficial at virtually all ages, improves overall health, reduces healthcare costs and improves quality of life, which in turn aids in growth of the smoking cessation and nicotine de-addiction products market. However, well-designed smoking cessation research needs to be done, especially with adolescent smokers. Adolescent smokers are a rapidly growing population. As a population, they comprise a significant number of people, but their health risks and associated costs are not well studied. Understanding and reducing the burden of smoking on these young people can be effective in the effort to reduce the tobacco industry's enormous revenue.
It is estimated that approximately three million teenagers in the United States smoke cigarettes. This estimate does not include many adolescents in other parts of the world who are affected by smoking prevalence. According to the 2018 National Survey on Drug Use and Health, in the U.S., around 164.8 million people aged 12 or older in the U.S. were past month substance users that included tobacco, alcohol, or illicit drugs. Such high number of substance users is expected to aid in growth of the smoking cessation and nicotine de-addiction products market.
Smokers have higher incidences of many serious illnesses, some of which are heart diseases and cancers. As cigarette demand increases in countries outside of the United States and Canada, smoking prevalence rises along with rates of heart disease and cancers. It is estimated that the eastern part of Canada (where smoking prevalence has been traditionally lowest) accounts for one fourth of all heart disease deaths in the world. Such incidence is expected to aid in growth of smoking cessation and nicotine de-addiction products market in North America.
Several studies have revealed that there may be a strong connection between nicotine use and depression in patients diagnosed with depression. Specifically, the study found that nicotine replacement therapy (NRT) and e-cigarettes were as effective at treating depression as Zyban, an anti-depressant medication. Thus, increasing demand for NRT and e-cigarettes is also expected to aid in growth of the smoking cessation and nicotine de-addiction products market.
Smoking cessation specialists are touting the benefits of NRT and e-cigarettes, but they acknowledge that there is still a long way to go towards the ultimate goals of a smoke-free world. The best solution to stop smoking is still a drug therapy, one that works over time, as opposed to instantly treating symptoms. The Canadian government and health organizations have begun examining the transdermal patches as a possible smoking cessation solution. These transdermal patches are designed to release a slowly increasing amount of nicotine into the body via the skin's pores. Such initiatives aid in growth of the smoking cessation and nicotine de-addiction products market.
Comments
Post a Comment